‘I’ve spent £20,000 on prostate cancer drug – but this new test could save NHS money’

Giles Turner, 64, has had high-risk prostate cancer since 2023 and has spent £20,000 on the drug abiraterone (Picture: Giles Turner)

A new AI test can detect which men with high-risk prostate cancer could benefit from a life-extending drug.

The technology studies images of tumour samples and picks out features the human eye cannot see.

It then gives patients a score – biomarker-positive or -negative – to determine who will require abiraterone – a drug that inhibits testosterone production in the tumour.